|TABLE OF CONTENTSCluster's lifeOur member's newsSave the dateCalls for projectsAround our themes|
Following the very positive results presented in its annual report for the year 2017, Lyonbiopôle will continue to propose to its members to register in many upcoming events.
For example, you can take part in the “Space and Healthcare meet each other” event during a networking day organised with CNES or in the 6th edition of Medinov in Grenoble.
In this newsletter, you will also learn more about the newly launched project MAGIA dedicated to medical technologies.
We look forward to meeting in March at our events!
|Lyonbiopole confirms its dynamism in 2017The year 2017 and the 3.0 phase show resolutely positive results. Economic development, scientific animation, stimulation of innovation and international support allow Lyonbiopole to achieve its main objective. [...]|
|MAGIAThe MAGIA project brings together four European leading Medtech and Health clusters – BioPmed (Piedmont), BioWin (Wallonia), Life Science Nord (Northern Germany) and Lyonbiopole (Auvergne-Rhône-Alpes) – willing to foster and support the Medtech SME’s internationalisation through the creation of a strong and sustainable Medtech Alliance. [...]|
|Success for the prospective regional workshop on “probiotics and intestinal microbiota”Lyonbiopole proposed a prospective workshop focussed on the modulation of the intestinal microbiota. Built in collaboration with the PRI and supported by BIOASTER and ARC 1, this day brought together a total of 88 participants. […]|
|bioXclusters plus publishes its second newsletterBioXclusters plus, the European cluster alliance on Personalized Healthcare, coordinated by Lyonbiopole, publishes its second and last newsletter. It presents the results of the two years’ project; you will also discover testimonies from European SMEs that have been supported by the international partners of the Alliance. […]|
|New memberAt the cutting edge of research in the field of bioimpedance, BioparHom designs, produces and markets medical equipment for analyzing body composition. […]|
|Focus onSUBLIMED obtains the CE mark. This major step allows SUBLIMED to commercialize in France, as of now, its medical device actiTENS for the management of chronic pain patients. […]|
|February 1st, 2018NORAKER Receives Funding from the EIC SME Instrument Programme for its Innovative Technologies !||February 12th, 2018Roivant and Poxel Announce Strategic Agreement for Development and Commercialization of Imeglimin||February 12th, 2018Nosopharm receives ¤1 Million loan from BPIFrance|
|February 13th, 2018Erytech selects triple negative breast cancer as next indication for Eryaspase.||February 20th, 2018Biom’Up completes the first of its financing operations for a total amount of more than ¤40 million||February 20th, 2018Osivax appoints Prof. Jeffrey Almond as Chairman of its Scientific Advisory Board|
|February 23th, 2018ELSALYS BIOTECH concludes with THEA a license option agreement on its ELB011 program in ophthalmology||February 27th, 2018Poxel Presents Preclinical Proof-of-Concept Data|
|Spectrum Workshop – Tangential flow filtration using hollow fiber filters|
March 8th, 2018Space and Healthcare meet each other
March 29th, 2018Pall Life Sciences
May 5th, 2018SAVE THE DATE : General Assembly
May 31th, 2018
March 12th, 2018
March 21th, 2018
June 19th, 2018
October 18th, 2018
See All events
EUROPE & INTERNATIONAL
Before March 14th, 2018
Before March 22th, 2018
Before April 17th, 2018
Before April 18th, 2018
Before April 24th, 2018
Before April 24th, 2018
Before May 3th, 2018
March 13th, 2018
March 22th, 2018
March 23th, 2018
May 17th, 2018
May 17th, 2018
This email has been sent automatically to [[EMAIL_TO]]. Click here to unsubscribe.